Search results
David Benner Lombard, M.D., Ph.D. Department: Pathology and Laboratory Medicine. 305-243-6856 305-243-3518 dbl68@miami.edu Research/Lab Website.
Jan 16, 2017 · David Lombard, MD, PhD. University of Michigan. Disease Area. Oncology. Focus. Development of New Treatments for Metastatic Melanoma. Scholar Profile. 2017 Harrington Scholar-Innovator. The Lombard lab proposes development of new therapies that inhibit the mechanism that prevents cell death in melanoma.
Oct 14, 2022 · David B. Lombard, M.D., Ph.D., has been named co-leader of the Cancer Epigenetics Program at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
David Benner Lombard, M.D., Ph.D. Clinical Professor Publications Biography: Dr. Lombard received his MD from Harvard Medical School, and his PhD at MIT, where he studied Werner syndrome and related progerias. After Pathology residency at the Brigham and Women’s Hospital in Boston, Dr. Lombard pursued postdoctoral work in the area of sirtuin ...
Dr. Lombard was the first to describe a central role for SIRT3 in regulating mitochondrial protein acetylation. Subsequent studies have revealed that SIRT3 is a major player in regulating metabolism, cancer, the pro-longevity calorie restriction response, and cardioprotection.
David B. Lombard, MD, PhD Email: dbl68@miami.edu
David Lombard, MD, PhD. Associate Professor of Pathology . The focus of our laboratory is the sirtuin protein family. The sirtuins are NAD+-dependent protein deacetylases that regulate metabolism, genomic stability, and other diverse aspects of cell biology in organisms ranging from yeast to mammals.
8.0/10 (17320 reviews)
Get Round The Clock Access To Verified & Certified Doctors. Save Time & Money. Certified & Verified Doctors Will Answer All Your Medical Questions
A+ Rating - Better Business Bureau